Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

SoftBank Vision Fund 2 led autistic childcare platform developer Elemy’s latest round, which valued it at $1.15bn.

Prosus Ventures has returned to back an equity and debt round for the homecare management platform developer secured at a $1.25bn valuation.

Helena backed Twin Health, the developer of a metabolic digital twin platform, in a round reportedly valuing it at $740m.

The cancer drug developer has closed its initial public offering after underwriters exercised the greenshoe option.

M Ventures has returned to back the cancer therapeutics developer’s $75.5m round, five years after taking part in its series A.

Data collaboration software producer Duality Technologies, e-commerce logistics provider Pandion and cybersecurity software developer Adaptive Shield each raised $30m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The cancer drug developer has closed an initial public offering which took place alongside a $160m SoftBank-led private placement.

The small molecule drug developer has raised a series B round that brought its total funding to more than $100m.